Parkinson’s medication supply issues

Pharmaceutical companies have shared with us that they're facing supply problems for various reasons with the following Parkinson's medications:

Teva

• Carbidopa/levodopa 25mg/100mg controlled release tablets x 60 will experience supply problems until early December 2024.
• Carbidopa/entacapone/levodopa 31.25mg/200mg/125mg tablets x 30 will experience supply issues until the end of February 2024.
• Carbidopa/entacapone/levodopa 37.5mg/200mg/150mg tablets x 30 will experience supply issues until the end of February 2024.
• Pramipexole 2.10mg prolonged release tablets x 30 will face supply problems until the end of March 2024.
• Rasagiline 1mg tablets x 28 will face supply problems until June 2024.
• Ropinirole 0.25mg, 0.5mg and 2.0mg tablets will face supply problems until late 2025.

Will this affect me?

If you take the products listed above, your pharmacist may be unable to give you your prescription.

There may be alternative medicines available, which your GP or pharmacist should be able to discuss and prescribe for you.

Please note this is a national snapshot of medicine supply issues, it's important to check with your local pharmacy, as they may have your medicines in stock.

GPs and pharmacists can seek advice from their NHS pharmacy procurement specialist or the Specialist Pharmacy Service.

Keeping you informed

We will share updates as we receive them from pharmaceutical companies about any supply issues and action they're taking to ensure their products are available for people with Parkinson's.